UNITED STATES NEWS

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Sep 20, 2021, 5:20 AM | Updated: Sep 21, 2021, 5:31 pm
FILE - In this Dec. 15, 2020, file photo, a droplet falls from a syringe after a person was injecte...

FILE - In this Dec. 15, 2020, file photo, a droplet falls from a syringe after a person was injected with the Pfizer COVID-19 vaccine at a hospital in Providence, R.I. (AP Photo/David Goldman, File)

(AP Photo/David Goldman, File)

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters.

The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.

For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults getting the regular-strength shots, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press.

The kid dosage also proved safe, with similar or fewer temporary side effects — such as sore arms, fever or achiness — that teens experience, he said.

“I think we really hit the sweet spot,” said Gruber, who’s also a pediatrician.

Gruber said the companies aim to apply to the Food and Drug Administration by the end of the month for emergency use in this age group, followed shortly afterward with applications to European and British regulators.

Earlier this month, FDA chief Dr. Peter Marks told the AP that once Pfizer turns over its study results, his agency would evaluate the data “hopefully in a matter of weeks” to decide if the shots are safe and effective enough for younger kids.

An outside expert said scientists want to see more details but called the report encouraging.

“These topline results are very good news,” said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief. The level of immune response Pfizer reported “appears likely to be protective.”

Many Western countries so far have vaccinated no younger than age 12, awaiting evidence of what’s the right dose and that it works safely. Cuba last week began immunizing children as young as 2 with its homegrown vaccines and Chinese regulators have cleared two of its brands down to age 3.

While kids are at lower risk of severe illness or death than older people, more than 5 million children in the U.S. have tested positive for COVID-19 since the pandemic began and at least 460 have died, according to the American Academy of Pediatrics. Cases in children have risen as the delta variant swept through the country.

“I feel a great sense of urgency” in making the vaccine available to children under 12, Gruber said. “There’s pent-up demand for parents to be able to have their children returned to a normal life.”

In New Jersey, 10-year-old Maya Huber asked why she couldn’t get vaccinated like her parents and both teen brothers have. Her mother, Dr. Nisha Gandhi, a critical care physician at Englewood Hospital, enrolled Maya in the Pfizer study at Rutgers University. But the family hasn’t eased up on their masking and other virus precautions until they learn if Maya received the real vaccine or a dummy shot.

Once she knows she’s protected, Maya’s first goal: “a huge sleepover with all my friends.”

Maya said it was exciting to be part of the study even though she was “super scared” about getting jabbed. But “after you get it, at least you feel like happy that you did it and relieved that it didn’t hurt,” she told the AP.

Pfizer said it studied the lower dose in 2,268 kindergartners and elementary school-aged kids. The FDA required what is called an immune “bridging” study: evidence that the younger children developed antibody levels already proven to be protective in teens and adults. That’s what Pfizer reported Monday in a press release, not a scientific publication. The study still is ongoing, and there haven’t yet been enough COVID-19 cases to compare rates between the vaccinated and those given a placebo — something that might offer additional evidence.

The study isn’t large enough to detect any extremely rare side effects, such as the heart inflammation that sometimes occurs after the second dose, mostly in young men. The FDA’s Marks said the pediatric studies should be large enough to rule out any higher risk to young children. Pfizer’s Gruber said once the vaccine is authorized for younger children, they’ll be carefully monitored for rare risks just like everyone else.

A second U.S. vaccine maker, Moderna, also is studying its shots in elementary school-aged children. Pfizer and Moderna are studying even younger tots as well, down to 6-month-olds. Results are expected later in the year.

___

AP journalist Emma Tobin contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

United States News

FILE -- In this Aug. 24, 2021, file photo an ambulance sits outside the emergency room at The Queen...
Associated Press

What the No Surprises Act means for your medical bills

More Americans worry about unexpected medical bills than any other expense, according to polls by the Kaiser Family Foundation in 2018 and 2020. Unfortunately, those bills aren’t rare: 18% of emergency visits and 16% of in-network hospital stays had at least one out-of-network charge, a 2020 Peterson-KFF Health System Tracker study found. The No Surprises […]
6 hours ago
FILE - This Oct. 16, 2012, file photo, shows a portion of the UnitedHealth Group Inc.'s campus in M...
Associated Press

Optum again a big revenue driver for UnitedHealth in 2021

MINNETONKA, Minn. (AP) — UnitedHealth Group posted strong fourth-quarter earnings led by double-digit growth in its Optum division. The largest U.S. health insurer posted fourth quarter net income on Wednesday of $4.07 billion, or $4.26. Removing one-time benefits and charges, per-share earnings were $4.48, or 18 cents better than expected on Wall Street, according to […]
6 hours ago
A man looks at an electronic stock board of a securities firm in Tokyo, Wednesday, Jan. 19, 2022. A...
Associated Press

Global shares mostly fall after retreat on Wall Street

TOKYO (AP) — Global shares mostly fell in cautious trading on Wednesday, with Tokyo’s Nikkei 225 down nearly 3%, after stocks on Wall Street sank to a new low for the year. France’s CAC 40 added 0.1% to 7,138.95, while Germany’s DAX shed 0.3% to 15,720.91. Britain’s FTSE 100 sank 0.1% to 7,556.70. The futures […]
1 day ago
CORRECTS THE YEAR TO 2022, NOT 2021 - FILE - An Emirates jetliner comes in for landing at the Dubai...
Associated Press

Major airlines cancel, change flights to US over 5G dispute

DUBAI, United Arab Emirates (AP) — Major international airlines canceled flights heading to the U.S. or changed the planes they’re using Wednesday, the latest complication in a dispute over concerns that 5G mobile phone service could interfere with aircraft technology. Some airlines said they were warned that the Boeing 777, a plane used by carriers […]
1 day ago
Secretary of State Antony Blinken, second from right, is greeted by Ukrainian Deputy Foreign Minist...
Associated Press

Blinken urges unity to fight ‘relentless’ Russian aggression

KYIV, Ukraine (AP) — U.S. Secretary of State Antony Blinken urged western nations Wednesday to remain united in the face of what he called “relentless” Russian aggression against Ukraine and reassured Ukraine’s leader of their support. Blinken told Ukrainian President Volodymyr Zelenskyy during a visit to Kyiv that the U.S. and its allies were steadfast […]
1 day ago
FILE - A Lebanese man walks past the damaged former Israeli Khiam prison, Aug. 16, 2006, in the sou...
Associated Press

Family seeks to sue Lebanon over dead father’s captivity

CONCORD, N.H. (AP) — A Lebanese American man’s survivors, who filed an ambitious lawsuit last year alleging Lebanon’s security agency kidnapped and tortured him before he died in the U.S., hope to find an opening after the agency recently responded in an American court. Amer Fakhoury died in the United States in August 2020 at […]
1 day ago

Sponsored Articles

...
ENVOQUE MD

Thyroid issues: Here are the warning signs and what to do

In a 100-person office in the United States, an estimated 12 co-workers, employees and loved ones, will likely develop a thyroid condition during their lifetime. That’s because, according to the American Thyroid Association, more than 12% of the U.S. population will experience thyroid issues.
...
Arizona State University

Gain insights on next year’s trends at 58th Annual Economic Forecast Luncheon

Employment is recovering from the severe contraction induced by the pandemic, but it is still way below levels at the start of 2020. Can it fully recover in the coming year?
(Facebook Photo/NHTSA)...
Sweet James

Upcoming holiday season is peak time for DUI arrests

The holiday season may be the most wonderful time of the year, but it’s also the most dangerous time of the year to be driving. That’s why it’s important to remember to call Sweet James Accident Attorneys if you’re injured or arrested because of a DUI accident.
Pfizer says COVID-19 vaccine works in kids ages 5 to 11